• Thumbnail for Chugai Pharmaceutical Co.
    Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by...
    7 KB (591 words) - 11:17, 4 April 2024
  • Thumbnail for Chugai' Pictograph Site
    The Chugai' Pictograph Site is a prehistoric rock art site on the island of Rota in the Northern Mariana Islands. The rock art is located in a limestone...
    2 KB (160 words) - 01:22, 31 December 2021
  • Chugai Travel Co., Ltd. (中外旅行社, Chugai Ryokousha) is a travel agency based in Taitō, Tokyo, Japan. It is a Zainichi Korean Chongryon-affiliated company...
    4 KB (401 words) - 04:42, 11 October 2023
  • Thumbnail for The Nikkei
    newspaper department of Mitsui & Company in 1876 when it started publication of Chugai Bukka Shimpo (literally Domestic and Foreign Commodity Price Newspaper)...
    10 KB (815 words) - 17:45, 16 April 2024
  • Thumbnail for Gotō Chūgai
    Gotō Chūgai (後藤 宙外, 23 December 1866 – 12 June 1938) was the pen-name of Gotō Toranosuke, a Japanese essayist, novella writer, and literary critic active...
    3 KB (178 words) - 09:35, 4 October 2020
  • Thumbnail for Avutometinib
    being developed as a potential treatment for cancer. It was discovered by Chugai Pharmaceutical Co. (a subsidiary of Roche) through derivatization of a hit...
    3 KB (183 words) - 22:47, 29 January 2023
  • prostate cancer. Tocilizumab was jointly developed by Osaka University and Chugai, and was licensed in 2003 by Hoffmann-La Roche. Tocilizumab was approved...
    42 KB (3,568 words) - 02:59, 27 April 2024
  • Pharma Ltd Cephalon – Cephalon UK Ltd Chemidex – Chemidex Pharma Ltd ChugaiChugai Pharmaceutical Co. UK Ltd Colgate-Palmolive – Colgate-Palmolive Ltd...
    8 KB (815 words) - 09:15, 2 April 2024
  • clinical trial were published in March 2017. Nemolizumab was invented by Chugai, who sold an exclusive license for the drug's development and worldwide...
    3 KB (167 words) - 04:36, 14 January 2024
  • Thumbnail for Basimglurant
    modulator of the mGlu5 receptor which is under development by Roche and Chugai Pharmaceutical for the treatment of treatment-resistant depression (as an...
    7 KB (597 words) - 19:07, 7 December 2023